Residual lymph node tumour burden following removal of a single axillary sentinel lymph with macrometastatic disease in women with screen-detected invasive breast cancer
Author(s) -
Rajiv Dave,
Shan Cheung,
Mark Sibbering,
Olive Kearins,
Jacquie Jenkins,
Ashu Gandhi
Publication year - 2020
Publication title -
bjs open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.974
H-Index - 9
ISSN - 2474-9842
DOI - 10.1093/bjsopen/zraa022
Subject(s) - medicine , sentinel lymph node , breast cancer , sentinel node , mastectomy , biopsy , axillary lymph node dissection , axilla , breast conserving surgery , breast carcinoma , lymph node , surgery , radiology , cancer
Women with screen-detected invasive breast cancer who have macrometastatic disease on axillary sentinel lymph node biopsy (SLNB) are usually offered either surgical axillary node clearance (ANC) or axillary radiotherapy. These treatments can lead to significant complications for patients. The aim of this study was to identify a group of patients who may not require completion ANC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom